Sulforaphane alleviates membranous nephropathy by inhibiting oxidative stress-associated podocyte pyroptosis

Sulforaphane alleviates membranous nephropathy by inhibiting oxidative stress-associated podocyte pyroptosis

Objective(s): To investigate the natural product sulforaphane (SFN) in protection of membranous nephropathy (MN) by inhibiting oxidative stress-associated podocyte pyroptosis. Materials and Methods: A passive Heymann nephritis (PHN) model was established and treated with SFN. Clinical manifestations...

Full description

Saved in:

Bibliographic Details
Main Authors:	Daoyuan Lv, Laping Chu, Yuan Du, Chunqing Li, Neng Bao, Yuqing Su, Gang Wang, Yanlie Zheng, Yafen Yu
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2025-02-01
Series:	Iranian Journal of Basic Medical Sciences
Subjects:	membranous nephropathy oxidative stress podocyte pyroptosis sulforaphane
Online Access:	https://ijbms.mums.ac.ir/article_25231_2dbd19502a8656c7c14dbc01690e99df.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sulforaphane regulates AngII-induced podocyte oxidative stress injury through the Nrf2-Keap1/ho-1/ROS pathway
by: Wen Lu
Published: (2024-12-01)

Tacrolimus repairs glomerular podocytes injury in rats with adriamycin induced nephropathy
by: CHEN Cai-ming, et al.
Published: (2020-01-01)

Modified Huangqi Chifeng decoction alleviates podocyte injury on rat with experimental membranous nephropathy
by: Meiying Chang, et al.
Published: (2025-12-01)

Effects of dapagliflozin on podocyte damage and oxidative stress in patients with diabetic nephropathy
by: Yajing Shi, et al.
Published: (2025-08-01)

Renalase protects against podocyte injury by inhibiting oxidative stress and apoptosis in diabetic nephropathy
by: Wu Yiru, et al.
Published: (2024-11-01)

Columbianetin protects from high-glycemic podocyte damage by regulating autophagy
by: Shi Lang, et al.
Published: (2021-01-01)

Sulforaphane alters the acidification of the yeast vacuole
by: Alexander Wilcox, et al.
Published: (2020-03-01)

Screening and Identification of Novel DNA Aptamer for Targeted Delivery to Injured Podocytes in Glomerular Diseases
by: Chao Zhou, et al.
Published: (2025-05-01)

Effects of autophagy in the process of diabetic nephropathy
by: LIU Nan, et al.
Published: (2015-01-01)

Sulforaphane in experimental hypertension
by: Ali Banigesh, et al.
Published: (2020-07-01)

METTL3 promotes podocyte pyroptosis in diabetic nephropathy through N6-methyladenosine modification of TRIM29 mRNA
by: Xiaohong Xu, et al.
Published: (2025-12-01)

Inhibition of angiotensin Ⅱ type 1 receptor on Renal Fibrosis and Podocyte Damage in Angiotensin Ⅱ-induced Hypertensive Nephropathy
by: Zhang He-ping, et al.
Published: (2022-04-01)

Astaxanthin attenuates diabetic kidney injury through upregulation of autophagy in podocytes and pathological crosstalk with mesangial cells
by: Mengqi Hong, et al.
Published: (2024-12-01)

Podocyte injury in diabetes mellitus
by: Irina Nikolaevna Bobkova, et al.
Published: (2014-10-01)

Sulforaphane as a preventive agent in Oral Cancer- A Systematic Review
by: M. Parasakthi, et al.
Published: (2024-06-01)

Correlation of segmental sclerosis （S） with podocyte hypertrophy or apical lesions and treatment response IgA nephropathy
by: Tu Yu-chi, et al.
Published: (2022-05-01)

Mitochondrial morphological aberrations and redistribution in podocytes with glomerular diseases
by: Yu Wang, et al.
Published: (2025-12-01)

Research Progress in Regulation of Sulforaphane Synthesis in Broccoli Sprouts
by: LI Cui, FANG Sheng, ZHAO Zhongliang, LIU Haijie
Published: (2025-01-01)

Sulforaphane Restores Mitochondrial β-Oxidation and Reduces Renal Lipid Accumulation in a Model of Releasing Unilateral Ureteral Obstruction
by: Ana Karina Aranda-Rivera, et al.
Published: (2025-02-01)

Sulforaphane from Brassica Oleracea Induces Apoptosis in Oral Squamous Carcinoma Cells via p53 Activation and Mitochondrial Membrane Potential Dysfunction
by: Pooja Narain Adtani, et al.
Published: (2025-03-01)

Endothelial eNOS deficiency causes podocyte injury through NFAT2 and heparanase in diabetic mice
by: Daisuke Katagiri, et al.
Published: (2024-11-01)

Insight into the Sulforaphane Content and Glucosinolate Profile of Broccoli Stems After Heat Treatment
by: Yu-Hong Zhang, et al.
Published: (2025-04-01)

Podocyte epithelial-mesenchymal transdifferentiation and glomerular disease
by: CHEN Hai-yun, et al.
Published: (2020-01-01)

Insights from Metabolomic and Transcriptomic Analyses into Sulforaphane’s Protective Mechanism Against Deoxynivalenol Toxicity via Spermine Regulation
by: Yeyi Xiao, et al.
Published: (2025-04-01)

Podocyte dysfunction driven by heme in sickle-cell nephropathy
by: Chloé Ben Ali, et al.
Published: (2025-07-01)

Sulforaphane acutely activates multiple starvation response pathways
by: Kendra S. Plafker, et al.
Published: (2025-01-01)

LncRNA evf‐2 Exacerbates Podocyte Injury in Diabetic Nephropathy by Inducing Cell Cycle Re‐entry and Inflammation Through Distinct Mechanisms Triggered by hnRNPU
by: Chaojie Zhang, et al.
Published: (2024-12-01)

Anticancer activity of sulforaphane against human hepatoblastoma cells involves apoptosis, autophagy and inhibition of β-catenin signaling pathway
by: Junshan Lin, et al.
Published: (2020-06-01)

Research Pogress on Action Mechanism of NLRP3 Inflammasome and Pyroptosis in Diabetic Nephropathy
by: LEI Zhenyun, et al.
Published: (2025-04-01)

SIRT1/PGC-1α-mediated mitophagy participates the improvement roles of BMAL1 in podocytes injury in diabetic nephropathy: evidences from in vitro experiments
by: Yanxia Rui, et al.
Published: (2025-01-01)

Broccoli for the brain: a review of the neuroprotective mechanisms of sulforaphane
by: Riley N. Bessetti, et al.
Published: (2025-07-01)

Utilizing Podocyte Foot Process Morphology for the Identification of Diabetic Nephropathy with or without Minimal Change Disease: Establishment of an Artificial Intelligence-Assisted Diagnostic Model
by: Li X, et al.
Published: (2025-07-01)

Recent advances in understanding the mechanisms by which sodium-glucose co-transporter type 2 inhibitors protect podocytes in diabetic nephropathy
by: Xinqi Chen, et al.
Published: (2025-03-01)

Identification and functional analysis of energy metabolism and pyroptosis-related genes in diabetic nephropathy
by: Shan He, et al.
Published: (2025-02-01)

A KDM6A–KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction
by: Chun‐Liang Lin, et al.
Published: (2019-04-01)

PLA2R1 Overexpression Causes Podocyte Injury by Inhibiting the Cell Cycle: A Clinical Cross-Sectional Investigation and Cellular Study
by: Liang W, et al.
Published: (2025-06-01)

Sulforaphane’s Role in Osteosarcoma Treatment: A Systematic Review and Meta-Analysis of Preclinical Studies
by: Polymnia Louka, et al.
Published: (2025-04-01)

Astragaloside IV relieves passive heymann nephritis and podocyte injury by suppressing the TRAF6/NF-κb axis
by: Yuhua Ma, et al.
Published: (2024-12-01)

Effect of Sulforaphane on Colon Cancer Cell Invasion and Metastasis
by: MA Yutong, JIAO Yingshuai, LIU Shuyu, WU Junjie, YU Wenlong, WANG Xianghong
Published: (2025-07-01)

Sulforaphane Wrapped in Self-Assembled Nanomicelle Enhances the Effect of Sonodynamic Therapy on Glioma
by: Yihong Li, et al.
Published: (2024-12-01)